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doi:10.1016/j.ejvs.2010.05.017Abstract Background: Studies reporting outcomes following staged/synchronous carotid re-
vascularisation prior to cardiac surgery have generally concluded that procedural strokes are
reduced. However, virtually none have commented specifically on the risk of stroke in patients
with bilateral carotid disease who then undergo their cardiac procedure in the presence of an
unoperated, contralateral stenosis. If carotid disease really was an important cause of peri-
operative stroke, these patients should incur a much higher risk of stroke following their
cardiac procedure.
Methods: Retrospective audit of prospectively acquired data in 132 consecutive patients
undergoing synchronous carotid endarterectomy and cardiac surgery.
Results: Overall 30-day rates of mortality, ipsilateral stroke and any stroke were 5.3%, 1.5%
and 3% respectively. The 30-day rate of death/stroke was 6.8%. In 51 patients with a prior
history of stroke/TIA, the 30-day rate of death/stroke was 5.9%, compared with 7.4% in neuro-
logically asymptomatic patients. The majority (57%) had significant bilateral disease and
underwent their combined procedure in the presence of a significant, non-operated (asymp-
tomatic) contralateral stenosis (50e99%Z 75, 60e99%Z 54, 70e99%Z 32). Only one patient
(90e99% stenosis) suffered a post-operative stroke in the hemisphere ipsilateral to the non-
operated, contralateral stenosis.
Conclusions: Patients undergoing synchronous procedures incurred a low rate of procedural
stroke, perhaps justifying this management approach. However, an alternative and more crit-
ical analysis suggested that the risk of procedural stroke in patients with significant (non-oper-
ated) contralateral asymptomatic carotid disease was extremely low. This challenges the
assumption that asymptomatic carotid disease is an important cause of stroke during cardiac
surgery.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.16 2523179.
.nhs.uk
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304 A.R. Naylor“The great tragedy of science. The slaying of a beautiful
hypothesis by an ugly fact”
Thomas Hardy (1825e1895)Introduction
The management of patients undergoing cardiac surgery in
the presence of significant carotid disease is an enduringly
controversial subject, often attracting totally polarised
interpretations of the same literature.1e5 One of the most
controversial issues is whether asymptomatic carotid
disease is an important aetiological factor in stroke after
cardiac surgery, or simply a marker of increased risk.2,6,7
The aim of the current study was to analyse the outcomes
of a series of patients undergoing synchronous carotid and
cardiac revascularisation, both conventionally, and then in
analternativemanner in order to determine the risk of stroke
in patients with bilateral carotid disease who then under-
went a unilateral carotid endarterectomy plus cardiac
procedure in the presence of an unoperated, contralateral
significant stenosis. If carotid disease reallywas an important
cause of post-operative stroke, these patients should incur
amuch higher risk of stroke. If the risk of stroke was found to
be low, this would cast significant doubt upon the rationale
for offering staged or synchronous interventions in neuro-
logically asymptomatic patients undergoing cardiac surgery.Materials and Methods
A retrospective review was undertaken of prospectively
audited outcome data regarding 30-day morbidity and
mortality in 132 consecutive patients undergoing synchro-
nous carotid endarterectomy (CEA) and cardiac surgery
between March 1995 and December 2009. All of the carotid
procedures were performed by one vascular surgeon. The
Leicestershire, Northamptonshire and Rutland Research
Ethics Committee advised that this study did not fall under
the remit of the NHS Research Ethics Committee as it was
audit/service evaluation.
Case selection
The study cohort was primarily derived from patients
undergoing cardiac surgery at the Glenfield Hospital,
Leicester who were found (during pre-assessment) to have
significant carotid disease. Unit policy required that cardiac
surgery patients who; (i) reported a prior history of stroke
or transient ischaemic attack (TIA), or (ii) had an audible
carotid bruit, or (iii) were found to have significant left
mainstem disease following coronary angiography should
undergo a pre-operative Duplex ultrasound scan. This
evaluated the extracranial carotid arteries, as well as flow
in the subclavian and extracranial vertebral arteries. It is,
therefore, accepted that an indeterminate number of
patients who were not screened (pre-operatively) by
ultrasound may have undergone their cardiac surgery in the
presence of a significant, asymptomatic carotid stenosis. A
much smaller cohort of patients (7/132) presented with
a history of very recent onset carotid territory symptomsand were considered to be too high risk to undergo isolated
CEA because of severe cardiac disease. None of the latter
patients were suitable for coronary artery stenting. The
term ‘neurologically asymptomatic’ refers to any patient
who did not report a prior history of carotid or verte-
brobasilar territory events. The term ‘neurologically
symptomatic’ refers to any patient who reported a history
of stroke or TIA in the carotid or vertebrobasilar territories
at any time in the past. It was not possible to reliably
determine whether previous neurological symptoms were
attributable to significant carotid disease as some of the
events could have happened some years earlier.
Prior to January 2004, cardiac surgery patients who had
significant unilateral or bilateral carotid disease (defined as
a unilateral (NASCET derived) 70e99% stenosis, bilateral
70e99% stenoses or a unilateral 70e99% stenosis plus
contralateral occlusion) underwent synchronous cardiac
and carotid revascularisation, irrespective of whether the
patient was neurologically asymptomatic or symptomatic.
The carotid artery supplying the dominant hemisphere was
preferentially reconstructed in neurologically asymptom-
atic patients with bilateral 70e99% stenoses, even if the
contralateral carotid artery had the more severe stenosis.
Following a series of systematic reviews of the published
literature in December 2003,8e10 it was decided that
management guidelines would remain the same except that
patients with an asymptomatic, unilateral 70e99% carotid
stenosis would not now undergo prophylactic CEA. The risks
of procedural stroke in patients with a unilateral asymp-
tomatic 70e99% stenosis undergoing isolated CABG since
January 2004 have been published elsewhere.7Procedure
Carotid endarterectomy was performed immediately prior
to median sternotomy. The carotid bifurcation was exposed
via an anterior sternomastoid incision. Prior to carotid
clamping, all patients received an intravenous dose of
5000 IU of unfractionated heparin. A standard endarterec-
tomy was performed using routine shunting (Pruitt-Ina-
hara), routine tacking of the proximal and distal intimal
steps (7:0 Prolene), with closure of the arteriotomy with
a vein patch harvested from the long saphenous vein in the
groin. Following completion of the carotid procedure,
haemostasis was checked and secured and the wound
temporarily closed pending formal closure after completion
of the cardiac procedure. This was in order to minimise the
risks of neck haematoma formation during the cardiac
procedure when high dose heparin was administered.
A variety of cardiac procedures were performed in this
series (Table 1) and all were performed with the patient on
cardiopulmonary bypass. No cardiac procedure in this series
was performed using either minimally invasive direct
coronary artery bypass grafting or offpump coronary artery
bypass grafting. Post-operatively, patients were nursed in
the Cardiac Surgery Intensive Care Unit prior to transfer
back to the cardiac surgery ward for ongoing care.
Following hospital discharge, patients returned for clinical
review by both the cardiac and vascular surgeons. For the
purposes of this study, primary endpoints were; (i) death,
(ii) any stroke and (iii) ipsilateral stroke within 30 days of
Table 1 Type of cardiac procedure performed synchro-







CABG þ MVR þ AVR 1
CABG þ LVA 3
CABG þ AVR 14
CABG þ MVR 5
CABG þ AVR þ LVA 1
TOTAL 132
Synchronous Cardiac and Carotid Revascularisation 305surgery. A stroke was defined as any new focal neurological
deficit (or any worsening of a pre-existing focal neurolog-
ical deficit) or coma that had not recovered fully within
24 h. Any patient suffering a stroke in the peri-operative
period underwent a CT scan and/or autopsy to determine
the likely cause. Secondary endpoints included 30-day rates
of; (i) death/ipsilateral stroke and (ii) death/any stroke.
Results
Between March 1995 and January 2010, 132 consecutive
patients underwent a synchronous cardiac and carotid
procedure where the carotid operations were performed by
the same vascular surgeon. Table 1 details the various
cardiac procedures undertaken in this series; 100 patients
underwent a primary coronary artery bypass graft (CABG).
Thirty-two patients underwent some other type of cardiac
procedure including; (i) CABG plus either valve replace-
ment or left ventricular aneurysm repair (nZ 24), (ii) redo
CABG (n Z 4), (iii) redo aortic or mitral valve replacement
(n Z 4) and (iv) primary aortic valve replacement (n Z 1).Table 2 30-day outcomes following synchronous carotid endart
Parameter nZ Death Ipsilateral stroke
All patients 132 7 (5.3%) 2 (1.5%)
Males 88 6 (6.8%) 2 (2.3%)
Females 44 1 (2.3%) 0 (0.0%)
Age <59 years 10 0 (0.0%) 0 (0.0%)
Age 60e69 years 43 4 (9.3%) 2 (4.7%)
Age 70e79 year 67 2 (3.0%) 0 (0.0%)
Age >80 years 12 (8.3%) 0 (0.0%)
Asymptomatic 81 5 (6.2%) 1 (1.2%)
Symptomatic 51 2 (3.9%) 1 (2.0%)
Unilat 70-99% 64 4 (6.3%) 0 (0.0%)
Bilat 70-99% 42 1 (2.4%) 1 (2.4%)
Occ þ 70-99% 26 2 (7.7%) 1 (3.8%)
‘Primary’ CABG 100 5 (5.0%) 1 (1.0%)
All others 32 2 (6.3%) 1 (3.1%)
No statistical significance was detected between any two categoricalTable 2 details the 30-day risks of death, any territory
stroke, ipsilateral stroke and the cumulative endpoints of
death/ipsilateral stroke and death/any stroke for the
entire patient cohort and for selected subgroups. The 30-
day risk of death was 5.3% (n Z 7). The 30-day risk of
ipsilateral stroke was 1.5% (nZ 2), while the 30-day risk of
‘any stroke’ was 3.0% (n Z 4). The 30-day risk of death/
ipsilateral stroke was 6.1% (nZ 8), while the risk of death/
any stroke was 6.8% (n Z 9). There was no significant
difference in any 30-day outcome when stratified for; (i)
gender, (ii) age, (iii) neurological symptom status, (iv)
severity/bilateral nature of the carotid disease and (v)
whether the cardiac procedure involved a primary CABG or
more complex intervention.
There were four post-operative strokes in this series.
Two were fatal; one following an ipsilateral intracranial
haemorrhage on day 6, the second patient never recovered
consciousness and died on day three following bilateral
carotid and vertebrobasilar territory ischaemic infarctions
(presumed secondary to atheroembolism from the aortic
arch). The third stroke (ischaemic, presumed embolic) was
ipsilateral to the operated CEA (normal carotid artery on
Duplex ultrasound). The fourth stroke was again ischaemic
and was contralateral to a non-operated 90%, previously
asymptomatic stenosis. Duplex imaging after the stroke
showed that the carotid artery was now occluded.
Table 3 presents the outcome data stratified for pre-
operative neurological symptom status and extent of
carotid disease. The procedural risks were relatively similar
in patients who were either neurologically asymptomatic or
symptomatic and the risks did not increase significantly in
patients with severe bilateral carotid stenoses or contra-
lateral occlusion. The 30-day risk of death/any stroke was
8.1% in neurologically asymptomatic patients with a unilat-
eral 70e99% stenosis, 6.9% in asymptomatic patients with
bilateral 70e99% stenoses and 6.7% in asymptomatic
patients with a 70e99% stenosis and a contralateral occlu-
sion. Parallel data for previously neurologically symptom-
atic patients were 3.7%, 9.7% and 9.1% respectively.erectomy and cardiac surgery.
Any stroke Death/ipsilateral stroke Death/any CVA
4 (3.0%) 8 (6.1%) 9 (6.8%)
3 (3.4%) 7 (8.0%) 7 (8.0%)
1 (2.3%) 1 (2.3%) 2 (4.5%)
0 (0.0%) 0 (0.0%) 0 (0.0%)
2 (4.7%) 5 (11.6%) 5 (14.0%)
2 (3.0%) 2 (3.0%) 3 (4.5%)
0 (0.0%) 1 (8.3%) 1 (8.3%)
2 (2.5%) 6 (7.4%) 6 (7.4%)
2 (3.9%) 2 (3.9%) 3 (5.9%)
1 (1.6%) 4 (6.3%) 4 (6.3%)
2 (4.8%) 2 (4.8%) 3 (7.1%)
1 (3.8%) 2 (7.7%) 2 (7.7%)
3 (3.0%) 5 (5.0%) 6 (6.0%)
1 (3.1%) 3 (9.4%) 3 (9.4%)
variables in this table using Fishers Exact Test.
Table 3 30-Day outcomes following synchronous carotid endarterectomy and cardiac surgery stratified for neurological
symptom status and stenosis severity.
Parameter nZ Death Ipsilateral stroke any stroke Death/ipsilateral stroke Death/any CVA
Asymptomatic
Unilat 70e99%a 37 3 (8.1%) 0 (0.0%) 1 (2.7%) 3 (8.1%) 3 (8.1%)
Bilat 70e99% 29 1 (3.4%) 1 (3.4%) 1 (3.4%) 2 (6.9%) 2 (6.9%)
Occlusion þ 70e99% 15 1 (6.7%) 0 (0.0%) 0 (0.0%) 1 (6.7%) 1 (6.7%)
Prior stroke/TIA
Unilat 70e99% 27 1 (3.7%) 0 (0.0%) 0 (0.0%) 1 (3.7%) 1 (3.7%)
Bilat 70e99% 13 0 (0.0%) 0 (0.0%) 1 (9.7%) 0 (0.0%) 1 (9.7%)
Occlusion þ 70e99% 11 1 (9.1%) 1 (9.1%) 1 (9.1%) 1 (9.1%) 1 (9.1%)
No statistical significance detected between any two categorical variables in this table using Fishers Exact Test.
a After January 2004, no synchronous procedures were performed in patients with a unilateral, asymptomatic 70e99% stenosis.
306 A.R. NaylorNo patient underwent bilateral CEAs in this series, but
a significant proportion underwent combined surgery in the
presence of bilateral carotid disease. Seventy-five patients
(57%) underwent a combined procedure in the presence of
a non-operated, contralateral asymptomatic 50e99%
stenosis and only one of these patients (1.3%) suffered
a stroke in the hemisphere ipsilateral to the non-operated,
contralateral stenosis (patient had a 90% stenosis pre-
operatively). Fifty-four patients (41%) underwent
a combined procedure in the presence of an asymptomatic
non-operated, contralateral 60e99% stenosis; only one
(1.9%) suffered a stroke ipsilateral to the non-operated
stenosis. Finally, 42 patients (32%) had bilateral, severe
(70e99%) stenoses at the time of undergoing their
combined procedure. One reported a prior history of
bilateral carotid territory symptoms. Accordingly, 41
patients underwent a combined procedure in the presence
of a severe, asymptomatic (non-operated) contralateral
stenosis. Only one of these patients (2.4%) suffered a stroke
ipsilateral to the non-operated 70e99% stenosis (70e79%
stenosis, n Z 21, no ipsilateral strokes; 80e89% stenosis,
nZ 10, no ipsilateral strokes; 90e99% stenosis, nZ 10, one
ipsilateral stroke).
Table 4 details the causes of death in this study. Five of
81 neurologically asymptomatic patients died within 30
days (6.2%), but only one was stroke related. This patient
died on day three having never recovered from anaes-
thesia. He had CT scan evidence of infarction in both
carotid and both vertebrobasilar territories and it is
assumed that this was an atheroembolic stroke originating
from the aortic arch. The four other deaths in neurologi-
cally asymptomatic patients were either cardiac in origin
(n Z 3) or followed multi-organ failure (n Z 1). Of these,
one patient undergoing a redo, redo CABG went into acute
left ventricular failure during the carotid procedure and
required insertion of an intra-aortic balloon pump prior to
undergoing his third CABG. He died of acute heart failure on
the operating table immediately following completion of
the cardiac procedure. The two other deaths in neurologi-
cally asymptomatic patients followed a cardiac arrest and
acute myocardial infarction respectively.
Two of 51 patients reporting a prior history of stroke
died in the first 30 days (3.9%). One followed acute onset
cardiac failure 6 h post-operatively, while the second fol-
lowed an intracranial haemorrhage on day 6.Discussion
The management of patients with combined carotid and
cardiac disease is enduringly controversial.1e5 For many,
the classical questions about whether CEA should be
staged, reverse staged or synchronous9,10 or if aortic
atheroembolism is the principle cause of peri-operative
stroke3 have been overtaken by more contemporary
debates about whether carotid artery stenting (CAS) is the
safer and preferred alternative.11 However, while each
camp (CEA/CAS) has its advocates and detractors, neither
usually questions whether prophylactic carotid revascular-
isation actually benefits the majority of cardiac surgery
patients. At first sight, the results in this series seem
supportive of a policy of performing synchronous carotid
and cardiac interventions. Out of a cohort of 132 patients,
only two (1.5%) suffered an ipsilateral stroke following
cardiac surgery, while only four (3.0%) suffered a stroke in
‘any’ vascular territory. Secondary endpoints included a 30-
day rate of death/ipsilateral stroke of 6.1% and a 30-day
risk of death/any stroke of 6.8%. These results, therefore,
compare very favourably with parallel data from systematic
reviews and meta-analyses9,10 (including those reporting
CAS outcomes11) and are well within the procedural risk
guidelines set by the American Heart Association.12
However, it sometimes pays to look beyond the head-
lines. The primary (only) reason for performing a staged or
synchronous carotid revascularisation prior to cardiac
surgery is to prevent procedural stroke. The prevention of
‘late’ stroke should not be considered to be a bona fide
indication for prophylactic intervention in this situation;
this is a bonus. Accordingly, it is important to first differ-
entiate between symptomatic and asymptomatic patients
when trying to determine the optimum management
strategy.
There is a paucity of good quality natural history data
regarding the risk of stroke after isolated cardiac surgery in
patients who report a prior history of TIA or stroke and who
are also found to have a significant carotid disease. This is
partly because relatively few patients do not then undergo
either staged or synchronous carotid revascularisation, but
also because systematic reviews suggest that patients with
a documented history of prior stroke/TIA face an almost
fourfold excess risk of procedural stroke (Odds Ratio 3.6
(95%CI 2.7e4.9)), while patients with a “>50%” carotid
Table 4 Cause of death after synchronous carotid and cardiac surgery relative to age, gender, severity of carotid disease, type
of cardiac procedure and timing of death.
Gender Age Prior stroke/TIA Carotid disease Cardiac procedure Cause of death Timing of death
Male 63 asymptomatic unilateral 70e99% redo, redo CABG LVF on table
Male 60 asymptomatic bilateral 70e99% redo AVR cardiac arrest 6 h
Female 81 previous stroke unilateral 70e99% CABG þ MVR cardiac failure 6 h
Male 71 asymptomatic unilateral 70e99% CABG multi territory stroke day 3
Male 65 asymptomatic occln þ 70e99% CABG MI day 5
Male 68 previous stroke occln þ 70e99% CABG ICH day 6
Male 68 asymptomatic bilateral 70e99% CABG multi-organ failure day 13
OcclnZ occlusion, AVRZ aortic valve replacement, MVRZ mitral valve replacement, LVFZ left ventricular failure, MIZ myocardial
infarction, ICH Z intracranial haemorrhage.
Synchronous Cardiac and Carotid Revascularisation 307stenosis incur a greater than fourfold excess risk of stroke
after cardiac surgery (Odds Ratio 4.3 (95%CI 3.2e5.7)).8 In
one of the few studies published to date, D’ Agostino
observed that the risk of stroke was 18% (5/28) in symp-
tomatic patients with a unilateral carotid stenosis under-
going isolated cardiac surgery, increasing to 26% (5/19) in
symptomatic patients with severe bilateral disease.13 This
compares with a <2% risk of stroke in neurologically
asymptomatic patients with no significant carotid disease
undergoing cardiac surgery.8 Accordingly, it would be hard
to criticise anyone who offered staged or synchronous CEA/
CAS to a neurologically symptomatic patient prior to
undergoing cardiac surgery, especially in the current era of
intervening as soon as possible after the index event in
symptomatic patients.14
But what about the neurologically asymptomatic patient?
During the course of a five year audit in the USA (2000e2004),
27,084 patients underwent staged or synchronous proce-
dures.15 The overall in-hospital stroke/death rate was 6.9%
(CAS), compared with 8.6% where CEA was performed
(p Z 0.1). However, 97% of these procedures were under-
taken in neurologically asymptomatic patients and this fact,
alone, would suggest that a large body of opinion (and
presumably evidence)must exist to support prophylacticCEA
or CAS in this type of patient and that the procedural risks are
significantly less than those found in patients undergoing
isolated cardiac surgery?. As will be seen, the latter
assumption may be open to question.
In the current series, neurologically asymptomatic
patients undergoing a combined procedure incurred a 7.4%
risk of death/any stroke at 30 days. This compares with
a 5.1% risk reported in a systematic review of 16 studies
where individual units stratified outcomes for both symp-
tomatic and asymptomatic patients10 and 9.1% in
a systematic review of staged CAS þ CABG. In the latter
study, 87% of patients were neurologically asymptomatic
and 82% had unilateral disease.11 The key question,
however, is whether a 30-day risk of death/stroke of
somewhere between 5 and 9% is significantly less than the
risk facing a patient should he/she not undergo prophy-
lactic carotid revascularisation.
The 30-day risk of death/stroke in the current series did
not really correlate with the extent of carotid disease in
asymptomatic patients (Table 3), ranging from 8.1% (unilat-
eral 70e99% stenosis) to 6.9% (bilateral 70e99% stenosis) and
6.7% (70e99% stenosis plus contralateral occlusion). In
January 2004, practice changed in Leicester wherebypatientswith aunilateral, asymptomatic 70e99% stenosis did
not thereafter undergo a prophylactic CEA. A five year audit
of outcomes in 61 patients with unilateral, asymptomatic
70e99% stenoses who underwent isolated CABG between
2004 and 20097 found that not one patient suffered a stroke
within 30days of their cardiac operation, although threedied
(all following cardiac events). Although compared against
historical controls, one cannot completely ignore the fact
that the 30-day risk of death stroke following synchronous
procedures in patientswith unilateral, asymptomatic carotid
stenoses performed between 1995 and 2009 (8.1%) was
almost twice as high as the 30-day risk of death/stroke in
similar patients who underwent isolated cardiac surgery
between 2004 and 2009 (4.9%7).
Leicester is not the only group to have reported
extremely low procedural stroke risks in asymptomatic
patients undergoing isolated cardiac surgery. Ghosh et al.6
have also reported that not one out of 50 patients with
70e99% asymptomatic carotid stenoses (unilateral Z 20,
bilateralZ 30) suffered a stroke following isolated cardiac
surgery (30-day death/stroke rate was 4%). On a similar
theme, Li has reported that 51 patients with an asymp-
tomatic 70e99% stenosis (80e99% in 16) underwent isolated
CABG procedures without incurring any strokes in the post-
operative period and that 95% of all strokes occurring after
cardiac surgery could not be attributed to carotid disease.2
These three studies challenge the prevailing viewpoint
that the presence of an asymptomatic carotid stenosis
significantly increases the risk of stroke in cardiac surgery
patients. If true, the rationale for performing staged or
synchronous carotid revascularisations becomes flawed.
The case against implementing an uncritical policy of
prophylactic carotid revascularisation in neurologically
asymptomatic patients undergoing cardiac surgery is also
supported by new data from the current study.
If carotid disease was such an important cause of stroke
after cardiac surgery, one would intuitively expect that
there should be an increased risk of stroke in the hemi-
sphere ipsilateral to an unoperated severe stenosis in
patients presenting with bilateral disease. That, of course,
is exactly the same rationale used by many surgeons and
interventionists for undertaking staged or synchronous
interventions in patients with unilateral carotid disease.
But what about the patient with bilateral disease?. Only
one of these arteries is reconstructed during staged/
synchronous procedures, leaving the other artery to be
potentially responsible for causing procedural strokes. In
308 A.R. Naylorthe current study, more than half of the study cohort (57%)
underwent their cardiac procedure in the presence of an
unoperated, contralateral 50e99% stenosis; 41% had
a 60e99% stenosis, while 32% had an unoperated 70e99%
stenosis. However, only one of these patients suffered
a stroke in the hemisphere ipsilateral to the non-operated
stenosis (this patient had a 90% asymptomatic stenosis pre-
operatively). Overall, the risk of stroke in the non-operated
hemisphere of 41 patients with contralateral 70e99%
stenoses was 2.4%. If one now includes the 26 additional
patients with contralateral occlusion (none of whom
suffered a stroke in the hemisphere ipsilateral to the
occlusion), only 1/101 patients with a 50e100% contralat-
eral, stenosis suffered a post-operative stroke in the
hemisphere ipsilateral to the non-operated ICA, compared
with 1/80 with 60e100% stenoses and 1/67 with 70e100%
stenoses. These data (not previously considered) again
challenge the assumption that asymptomatic carotid
disease is an important cause of stroke after cardiac
surgery.
In conclusion, while the outcome data reported in this
study suggest that patients undergoing synchronous carotid
and cardiac revascularisation incur a low overall rate of
procedural stroke, a more critical analysis suggests that the
risk of stroke in cardiac surgery patients with significant
asymptomatic carotid disease is extremely low. There is
a desperate need for better natural history studies and an
urgent need for guideline makers to review the quality of
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